Blue Owl Capital Holdings LP
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 14, 2026), Blue Owl Capital Holdings LP reported 54 stock positions worth $369.9 million. Its top holding was Aktis Oncology (AKTS) at 15.3% of the portfolio, followed by Larimar Therapeutics (LRMR, 8.7%) and Engene (ENGN, 8.1%). Compared with Q4 2025, it opened 19 new positions, sold out of 15, added to 11 and reduced 12. The biggest buy was a new position in Aktis Oncology (AKTS) and the biggest sale an exit from Repare Therapeutics (RPTX).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001858703
- Portfolio Value
- $369.9M (Q1 2026)
- SEC Filing
- 0001193125-26-223563 ↗ filed May 14, 2026
Holdings Value
Holdings 54 stocks · $369.9M
| AKTS Aktis Oncology Inc. | 15.29% | 3,161,348 | $56.6M | New |
| LRMR Larimar Therapeutics Inc. | 8.66% | 7,120,007 | $32.0M | Add +4.3% |
| ENGN Engene Holdings Inc. | 8.13% | 4,416,353 | $30.1M | Add +31.4% |
| NCDL Nuveen Churchill Direct Lend | 7.37% | 2,143,626 | $27.3M | No change |
| CGEM Cullinan Therapeutics Inc. | 7.34% | 1,909,764 | $27.1M | Reduce -18.8% |
| OBDC Blue Owl Capital Corp. | 6.11% | 2,045,070 | $22.6M | No change |
| MPLT Maplight Therapeutics Inc. | 5.53% | 1,005,929 | $20.5M | Add +207.6% |
| CMPX Compass Therapeutics Inc. | 4.21% | 2,941,525 | $15.6M | Reduce -15.1% |
| CNTX Context Therapeutics Inc. | 3.60% | 5,089,015 | $13.3M | Reduce -31.5% |
| HLLY Holley Inc. | 3.52% | 4,236,888 | $13.0M | Add +2.2% |
| EYPT Eyepoint Inc. | 3.18% | 912,594 | $11.8M | Add +132.4% |
| CRVS Corvus Pharmaceuticals Inc. | 2.16% | 545,000 | $8.0M | New |
| CNDT Conduent Inc. | 1.74% | 5,036,595 | $6.4M | Add +4.4% |
| RARE Ultragenyx Pharmaceutical Inc. | 1.71% | 302,638 | $6.3M | Add +42.3% |
| AQST Aquestive Therapeutics Inc. | 1.51% | 1,347,932 | $5.6M | Add +156.8% |
| RYTM Rhythm Pharmaceuticals Inc. | 1.44% | 61,455 | $5.3M | New |
| COMPASS PATHWAYS PLC | 1.39% | 1,804,504 | $5.1M | New |
| IMMX Immix Biopharma Inc. | 1.35% | 547,552 | $5.0M | Reduce -44.5% |
| IMA Imagenebio Inc. | 1.30% | 959,337 | $4.8M | Add +16.4% |
| CVEO Civeo Corp. | 1.29% | 180,475 | $4.8M | Reduce -51.3% |
| LENZ Lenz Therapeutics Inc. | 1.25% | 506,722 | $4.6M | Add +237.8% |
| ELDN Eledon Pharmaceuticals Inc. | 1.18% | 1,419,912 | $4.4M | Reduce -26.4% |
| KALV Kalvista Pharmaceuticals Inc. | 1.17% | 215,000 | $4.3M | Reduce -40.3% |
| OVID Ovid Therapeutics Inc. | 1.14% | 1,904,666 | $4.2M | New |
| PVLA Palvella Therapeutics Inc. | 1.05% | 31,259 | $3.9M | Reduce -22.4% |
| PLRX Pliant Therapeutics Inc. | 1.01% | 2,969,199 | $3.7M | No change |
| STWD Starwood Property Trust Inc. | 0.74% | 158,545 | $2.7M | New |
| ADCT Adc Therapeutics SA | 0.70% | 733,568 | $2.6M | No change |
| EVMN Evommune Inc. | 0.62% | 100,000 | $2.3M | New |
| DELL Dell Technologies -C | 0.62% | 13,899 | $2.3M | Reduce -74.2% |
| LARIMAR THERAPEUTICS INC | 0.52% | 975,700 | $1.9M | New |
| ORIC Oric Pharmaceuticals Inc. | 0.51% | 150,000 | $1.9M | Reduce -70.9% |
| SGMT Sagimet Biosciences Inc. Class A | 0.47% | 333,877 | $1.7M | Reduce -73.2% |
| WW WW International Inc.-New filed as WW INTL INC | 0.36% | 95,634 | $1.3M | New |
| ENGENE HOLDINGS INC | 0.35% | 511,177 | $1.3M | Add +1316.0% |
| EPD Enterprise Products Partners | 0.32% | 31,290 | $1.2M | No change |
| FLD Fold Holdings Inc. filed as FOLD HLDGS INC | 0.31% | 856,632 | $1.1M | No change |
| MRKR Marker Therapeutics Inc. | 0.19% | 554,250 | $721K | No change |
| MINERALYS THERAPEUTICS INC | 0.16% | 200,000 | $590K | New |
| COMPASS THERAPEUTICS INC | 0.14% | 400,000 | $500K | New |
| CAH Cardinal Health Inc. | 0.10% | 1,718 | $363K | No change |
| PIPR Piper Sandler Cos | 0.05% | 2,428 | $186K | No change |
| ALPHA MODUS HLDGS INC | 0.04% | 394,078 | $146K | No change |
| ET Energy Transfer LP | 0.03% | 5,326 | $103K | New |
| CID HOLDCO INC | 0.03% | 557,361 | $95K | No change |
| CAI Caris Life Sciences Inc. | 0.02% | 4,711 | $84K | New |
| VODAFONE GROUP PLC | 0.02% | 5,371 | $81K | New |
| VIKING THERAPEUTICS INC | 0.02% | 50,000 | $68K | New |
| SHFS SHF Holdings Inc. | 0.02% | 75,897 | $63K | No change |
| GOCOQ Gohealth Inc. Class A | 0.02% | 40,770 | $62K | New |
| AEON Aeon Biopharma Inc. | 0.01% | 42,353 | $42K | Reduce -2.4% |
| STRUCTURE THERAPEUTICS INC | 0.01% | 100,000 | $25K | New |
| OLEMA PHARMACEUTICALS INC | 0.00% | 200,000 | $10K | New |
| KPLT Katapult Holdings Inc. | 0.00% | 5,421 | $6K | New |
Other holdings (21): bonds, preferreds, convertibles and warrants · $2.2M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| OPTXW Omnilit Acquisition Class A -23 | *W EXP 99/99/999 | 803,132 | $867K | No change |
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | 320,100 | $525K | Reduce -63.5% |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | 1,666,808 | $417K | Reduce -38.9% |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | 235,121 | $202K | Reduce -18.7% |
| AMODW Insight Acquisition Co. -CW23 | *W EXP 12/13/202 | 1,854,665 | $74K | No change |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | 175,000 | $35K | No change |
| SLND.WS Legato Merger Corp. II -CW23 | *W EXP 02/14/202 | 860,302 | $34K | No change |
| RDZNW Vahanna Tech Edge -CW24 | *W EXP 11/30/202 | 225,000 | $32K | No change |
| BKSYW Blacksky Technology -CW24 | *W EXP 09/09/202 | 350,000 | $14K | No change |
| BDMDW Baird Medical Investment -28 | *W EXP 10/01/202 | 100,000 | $9K | No change |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | 444,515 | $9K | Add +48.2% |
| DAVEW Dave Inc. -CW27 | *W EXP 01/05/202 | 28,750 | $8K | No change |
| TVGNW Semper Paratus Acqu -CW26 | *W EXP 02/14/202 | 200,000 | $6K | No change |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | 16,666 | $3K | Reduce -47.4% |
| LIMNW Liminatus Pharma Inc. Class A-28 | *W EXP 04/30/203 | 50,000 | $2K | No change |
| PGYWW Pagaya Technologies Ltd. -27 | *W EXP 99/99/999 | 48,661 | $2K | No change |
| XBPEW CF Acquisition Viii A -CW27 | *W EXP 11/30/202 | 24,778 | $1K | No change |
| MLKWF Waldencast Acq Class A -CW27 | *W EXP 07/27/202 | 33,333 | $1K | No change |
| BTMWQ Bitcoin Depot Inc.-CW23 | *W EXP 06/30/202 | 50,000 | $1K | No change |
| ASBPW Aspire Biopharma Holdin-CW27 | *W EXP 02/14/203 | 50,000 | $1K | No change |
| KPLTW Katapult Holdings Inc. -CW26 | *W EXP 06/09/202 | 400,000 | $0 | No change |
Total filed on the 13F, all lines: $372.2M.
Portfolio Sells Q4 2025 → Q1 2026
| RPTX Repare Therapeutics Inc. | Sold out | 0.00% | −2.79 |
| PCOR Procore Technologies Inc. | Sold out | 0.00% | −2.14 |
| SGMT Sagimet Biosciences Inc. Class A | Reduce -73.2% | 0.47% | −1.82 |
| ROIV Roivant Sciences Ltd. | Sold out | 0.00% | −1.78 |
| CMPX Compass Therapeutics Inc. | Reduce -15.1% | 4.21% | −1.59 |
| DELL Dell Technologies -C | Reduce -74.2% | 0.62% | −1.50 |
| IMRX Immuneering Corp. Class A | Sold out | 0.00% | −1.36 |
| CVEO Civeo Corp. | Reduce -51.3% | 1.29% | −1.35 |
| PAYO Payoneer Global Inc. | Sold out | 0.00% | −1.24 |
| CNTA Centessa Pharmaceuticals Ltd. | Sold out | 0.00% | −1.09 |
| CMPS Compass Pathways PLC | Sold out | 0.00% | −1.01 |
| NU Nu Holdings Ltd./Cayman Isl-A | Sold out | 0.00% | −0.91 |
| ORIC Oric Pharmaceuticals Inc. | Reduce -70.9% | 0.51% | −0.80 |
| MLYS Mineralys Therapeutics Inc. | Sold out | 0.00% | −0.75 |
| KALV Kalvista Pharmaceuticals Inc. | Reduce -40.3% | 1.17% | −0.64 |
| JANX Janux Therapeutics Inc. | Sold out | 0.00% | −0.43 |
| CHYM Chime Financial Inc. Class A | Sold out | 0.00% | −0.31 |
| PVLA Palvella Therapeutics Inc. | Reduce -22.4% | 1.05% | −0.26 |
| IMMX Immix Biopharma Inc. | Reduce -44.5% | 1.35% | −0.26 |
| CGEM Cullinan Therapeutics Inc. | Reduce -18.8% | 7.34% | −0.25 |
| OMDA Omada Health Inc. | Sold out | 0.00% | −0.08 |
| TTAN Servicetitan Inc. Class A | Sold out | 0.00% | −0.08 |
| ANGX Angel Studios Inc. | Sold out | 0.00% | −0.01 |
| AEON Aeon Biopharma Inc. | Reduce -2.4% | 0.01% | −0.00 |
| BLNE Beeline Holdings Inc. | Sold out | 0.00% | 0.00 |
| CNTX Context Therapeutics Inc. | Reduce -31.5% | 3.60% | +0.20 |
| ELDN Eledon Pharmaceuticals Inc. | Reduce -26.4% | 1.18% | +0.27 |
Portfolio Buys Q4 2025 → Q1 2026
| AKTS Aktis Oncology Inc. | New | 15.29% | +15.29 |
| MPLT Maplight Therapeutics Inc. | Add +207.6% | 5.53% | +3.74 |
| CRVS Corvus Pharmaceuticals Inc. | New | 2.16% | +2.16 |
| RYTM Rhythm Pharmaceuticals Inc. | New | 1.44% | +1.44 |
| COMPASS PATHWAYS PLC | New | 1.39% | +1.39 |
| OVID Ovid Therapeutics Inc. | New | 1.14% | +1.14 |
| EYPT Eyepoint Inc. | Add +132.4% | 3.18% | +0.94 |
| STWD Starwood Property Trust Inc. | New | 0.74% | +0.74 |
| EVMN Evommune Inc. | New | 0.62% | +0.62 |
| LRMR Larimar Therapeutics Inc. | Add +4.3% | 8.66% | +0.56 |
| LARIMAR THERAPEUTICS INC | New | 0.52% | +0.52 |
| LENZ Lenz Therapeutics Inc. | Add +237.8% | 1.25% | +0.51 |
| AQST Aquestive Therapeutics Inc. | Add +156.8% | 1.51% | +0.46 |
| WW WW International Inc.-New | New | 0.36% | +0.36 |
| ENGENE HOLDINGS INC | Add +1316.0% | 0.35% | +0.32 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +42.3% | 1.71% | +0.19 |
| MINERALYS THERAPEUTICS INC | New | 0.16% | +0.16 |
| COMPASS THERAPEUTICS INC | New | 0.14% | +0.14 |
| ET Energy Transfer LP | New | 0.03% | +0.03 |
| CAI Caris Life Sciences Inc. | New | 0.02% | +0.02 |
| VODAFONE GROUP PLC | New | 0.02% | +0.02 |
| VIKING THERAPEUTICS INC | New | 0.02% | +0.02 |
| GOCOQ Gohealth Inc. Class A | New | 0.02% | +0.02 |
| STRUCTURE THERAPEUTICS INC | New | 0.01% | +0.01 |
| OLEMA PHARMACEUTICALS INC | New | 0.00% | +0.00 |
| KPLT Katapult Holdings Inc. | New | 0.00% | +0.00 |
| IMA Imagenebio Inc. | Add +16.4% | 1.30% | −0.47 |
| CNDT Conduent Inc. | Add +4.4% | 1.74% | −1.14 |
| ENGN Engene Holdings Inc. | Add +31.4% | 8.13% | −1.33 |
| HLLY Holley Inc. | Add +2.2% | 3.52% | −1.82 |
Notes & Other Activity Q4 2025 → Q1 2026
| NIOBW Niocorp Developments Ltd. -28 | *W EXP 03/17/202 | Reduce -63.5% | 320,100 | $525K |
| BNAIW Brand Engagement Netwo -CW27 | *W EXP 03/14/202 | Reduce -38.9% | 1,666,808 | $417K |
| DRTSW Alpha Tau Medical Ltd. -27 | *W EXP 99/99/999 | Sold out | 1,166,118 | $396Kbefore exit |
| RZLVW Rezolve AI PLC -CW27 | *W EXP 08/15/202 | Reduce -18.7% | 235,121 | $202K |
| LVWR.WS Livewire Group Inc.-27 | *W EXP 09/26/202 | Sold out | 500,000 | $30Kbefore exit |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | Sold out | 200,000 | $14Kbefore exit |
| ZEOWW Esgen Acquisition A -CW23 | *W EXP 03/13/202 | Sold out | 250,000 | $10Kbefore exit |
| DAICW Cid Holdco Inc. -26 | *W EXP 12/31/202 | Add +48.2% | 444,515 | $9K |
| BAERW Wildfire New Pubco Inc.-27 | *W EXP 01/24/202 | Sold out | 25,000 | $5Kbefore exit |
| BSLKW Golden Arrow Merger A -CW26 | *W EXP 08/13/202 | Sold out | 166,666 | $3Kbefore exit |
| SDSTW Global Partner Acq A -CW27 | *W EXP 06/21/202 | Reduce -47.4% | 16,666 | $3K |
| PDYNW Sarcos Technology -CW27 | *W EXP 09/24/202 | Sold out | 35,000 | $2Kbefore exit |
| CXAIW Kins Tech Group Class A -CW25 | *W EXP 99/99/999 | Sold out | 12,500 | $625before exit |
| SLXNW Biomotion Sciences-CW29 | *W EXP 08/15/202 | Sold out | 12,500 | $375before exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 48 | $656.7M | SPCX, AKTS, CGEM, LRMR, NCDL |
| Q1 2026 | 54 | $369.9M | AKTS, LRMR, ENGN, NCDL, CGEM |
| Q4 2025Amended | 50 | $320.9M | ENGN, NCDL, OBDC, LRMR, CGEM |
| Q3 2025 | 46 | $319.9M | NCDL, OBDC, ENGN, LRMR, EVCM |
| Q2 2025 | 46 | $308.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q1 2025 | 45 | $309.2M | NCDL, OBDC, CGEM, EVCM, TRML |
| Q4 2024 | 48 | $432.6M | NCDL, KVYO, PLRX, OBDC, CGEM |
| Q3 2024 | 68 | $514.6M | NCDL, KVYO, TRML, PLRX, CGEM |
| Q2 2024 | 40 | $359.5M | CGEM, PLRX, OBDC, KVYO, LRMR |
| Q1 2024 | 44 | $500.6M | HOOD, CGEM, PLRX, ENGN, TRML |